Enhertu

Medicinal product

(Invented) name

Enhertu

Active substance (s)

Trastuzumabas derukstekanas

Strength

100 mg

Pharmaceutical form

milteliai infuzinio tirpalo koncentratui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01FD04, trastuzumab deruxtecan

Marketing authorisation holder

Daiichi Sankyo Europe GmbH, Vokietija

Date of authorisation

2021-01-18

Date of renewal

Documents

Enhertu paciento kortele.pdf

Enhertu mokomoji medziaga sveikatos prieziuros specialistams.pdf

Enhertu mokomoji medziaga sveikatos prieziuros specialistams 2.pdf

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Powder for concentrate for solution for infusion	1 ml
Trastuzumabas derukstekanas	100 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
105664	91764	1091764	flakonas	N1		Receptinis	EU/1/20/1508/001	Tiekiama	2025-10-09	-	No	-	-

Stadijos

Data	Stadija
2021-01-18	Registruotas